Total synthesis of human chymase inhibitor methyllinderone and structure--activity relationships of its derivatives (Q43653075)

25 November 2017

title

Total synthesis of human chymase inhibitor methyllinderone and structure--activity relationships of its derivatives (English)

1 reference

25 November 2017

Aoyama Y

1 reference

25 November 2017

Konoike T

1 reference

25 November 2017

Kanda A

1 reference

25 November 2017

Naya N

1 reference

25 November 2017

Nakajima M

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

25 November 2017

published in

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

1695-1697

1 reference

Recombinant expression of human mast cell proteases chymase and tryptase

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Inhibition of chymase reduces vascular proliferation in dog grafted veins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Non-peptidic inhibitors of human chymase. Synthesis, structure-activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Structure-activity relationship studies of chloromethyl ketone derivatives for selective human chymase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Symmetrical anhydride-type serine protease inhibitors: structure-activity relationship studies of human chymase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

A dihydrochalcone from Lindera lucida

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

A synthetic method for formyl→ethynyl conversion (RCHO→RCCH or RCCR′)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Structure and antitumor activity relation of 2-arylidene-4-cyclopentene-1,3-diones and 2-arylideneindan-1,3-diones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

New Synthesis of 2-Substituted Cyclopentane-1, 3-dione

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900265-7

7 January 2021

Studies on the constituents of Lindera erythrocarpa Makino. III. The isolation and crystal structure of sodium lucidonate.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.25.1404

Identifiers

DOI

10.1016/S0960-894X(01)00265-7

1 reference

25 November 2017

1 reference